Biofrontera's market cap is currently $10.24M. The company's EPS TTM is $-0.57; its P/E ratio is ―; Biofrontera is scheduled to report earnings on August 13, 2025, and the estimated EPS forecast is $-0.48. See an overview of income statement, balance sheet, and cash flow financials.
